Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"Parstatin"”.
-
Πειραματική πρόκληση νεοαγγείωσης του κερατοειδούς
… is the major contributor to angiogenesis. Parstatin is a 41-mer peptide formed by proteolytic cleavage on activation of the PAR1 receptor and contains a hydrophobic and a hydrophilic domain. Recently it was demonstrated that parstatin is a potent inhibitor of angiogenesis. The purpose of …
-
Μελέτη της παρστατίνης σε οφθαλμικά κύτταρα: in vitro μελέτη κυτταροτοξικότητας σε κύτταρα του αμφιβληστορειδούς
Purpose: Parstatin, the N-terminal 41-amino-acid peptide cleaved by thrombin from protease-activated-receptor 1, was shown to be highly effective in preventing ocular angiogenesis and as such it has potential therapeutic applications in ocular neovascular diseases. In the frame of a safety program …
-
Μελέτη της προφυλακτικής δράσης της παρστατίνης έναντι της νεφροτοξικότητας των ιωδιούχων σκιαγραφικών μέσων κατά τη διάρκεια εξετάσεων με ψηφιακή αφαιρετική αγγειογραφία
… evidence that can prevent CIN development.Parstatin is the N-terminal-41-amino-acid peptide cleaved by thrombin from the protease-activated receptor-1. Low doses of Parstatin are known to have a protective effect in the rat myocardium after ischemia/reperfusion injury. The primary …
-
Functional analysis of the signal peptide of the Protease Activated Receptor 1 (PAR1)
… a peptide into the extracellular space, namely parstatin, which was recently shown to have a regulatory function in angiogenesis and in myocardial ischemia and reperfusion injury. It was previously thought that this extracellular parstatin peptide indeed contains residues Met1-Arg41. However, …
-
Η επίδραση της παρστατίνης 1-26 στη μυοκαρδιακή βλάβη από ισχαιμία και επαναιμάτωση: μελέτη σε πειραματικό μοντέλο κονίκλων
… administration of exenatide and cyclosporin A or parstatin 1-26 is more effective than monotherapies and may offer a more advantageous clinical effect.